Advertisement

Novo Nordisk: A Better Way To Invest in Diabetes Stocks

Diabetes treatment accounts for 80% of Novo Nordisk's sales and future revenue could benefit from a pipeline of new therapies, including an oral insulin tablet. This podcast was recorded on 09/09/2015.